These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 17959138)

  • 1. Comparative homology modeling of human cytochrome P4501A1 (CYP1A1) and confirmation of residues involved in 7-ethoxyresorufin O-deethylation by site-directed mutagenesis and enzyme kinetic analysis.
    Lewis BC; Mackenzie PI; Miners JO
    Arch Biochem Biophys; 2007 Dec; 468(1):58-69. PubMed ID: 17959138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of reciprocal active site mutations in human cytochromes P450 1A1 and 1A2 on alkoxyresorufin metabolism.
    Liu J; Ericksen SS; Sivaneri M; Besspiata D; Fisher CW; Szklarz GD
    Arch Biochem Biophys; 2004 Apr; 424(1):33-43. PubMed ID: 15019834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular modeling of cytochrome P450 1A1: enzyme-substrate interactions and substrate binding affinities.
    Szklarz GD; Paulsen MD
    J Biomol Struct Dyn; 2002 Oct; 20(2):155-62. PubMed ID: 12354067
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of LYS271 and LYS279 residues in the interaction of cytochrome P4501A1 with NADPH-cytochrome P450 reductase.
    Cvrk T; Strobel HW
    Arch Biochem Biophys; 2001 Jan; 385(2):290-300. PubMed ID: 11368010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of human cytochrome P450 2C8 substrate specificity using a substrate pharmacophore and site-directed mutants.
    Melet A; Marques-Soares C; Schoch GA; Macherey AC; Jaouen M; Dansette PM; Sari MA; Johnson EF; Mansuy D
    Biochemistry; 2004 Dec; 43(49):15379-92. PubMed ID: 15581350
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.
    Narimatsu S; Oda M; Hichiya H; Isobe T; Asaoka K; Hanioka N; Yamano S; Shinoda S; Yamamoto S
    Chem Biol Interact; 2005 Feb; 152(1):1-12. PubMed ID: 15766918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of CYP2D6 substrate interactions by computational methods.
    Ito Y; Kondo H; Goldfarb PS; Lewis DF
    J Mol Graph Model; 2008 Feb; 26(6):947-56. PubMed ID: 17764997
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequencing and characterization of mixed function monooxygenase genes CYP1A1 and CYP1A2 of Mink (Mustela vison) to facilitate study of dioxin-like compounds.
    Zhang X; Moore JN; Newsted JL; Hecker M; Zwiernik MJ; Jones PD; Bursian SJ; Giesy JP
    Toxicol Appl Pharmacol; 2009 Feb; 234(3):306-13. PubMed ID: 19041884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Selection and characterization of human cytochrome P450 1A2 mutants with altered catalytic properties.
    Parikh A; Josephy PD; Guengerich FP
    Biochemistry; 1999 Apr; 38(17):5283-9. PubMed ID: 10220313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of THR501 residue in substrate binding and catalytic activity of cytochrome P4501A1.
    Cvrk T; Strobel HW
    Arch Biochem Biophys; 2001 May; 389(1):31-40. PubMed ID: 11370669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Probing the promiscuous active site of myo-inositol dehydrogenase using synthetic substrates, homology modeling, and active site modification.
    Daniellou R; Zheng H; Langill DM; Sanders DA; Palmer DR
    Biochemistry; 2007 Jun; 46(25):7469-77. PubMed ID: 17539607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. cDNA cloning and characterization of feline CYP1A1 and CYP1A2.
    Tanaka N; Miyasho T; Shinkyo R; Sakaki T; Yokota H
    Life Sci; 2006 Nov; 79(26):2463-73. PubMed ID: 17097115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of substrate recognition in D-3-hydroxybutyrate dehydrogenase from Pseudomonas putida.
    Feller C; Günther R; Hofmann HJ; Grunow M
    Chembiochem; 2006 Sep; 7(9):1410-8. PubMed ID: 16888731
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Six novel nonsynonymous CYP1A2 gene polymorphisms: catalytic activities of the naturally occurring variant enzymes.
    Murayama N; Soyama A; Saito Y; Nakajima Y; Komamura K; Ueno K; Kamakura S; Kitakaze M; Kimura H; Goto Y; Saitoh O; Katoh M; Ohnuma T; Kawai M; Sugai K; Ohtsuki T; Suzuki C; Minami N; Ozawa S; Sawada J
    J Pharmacol Exp Ther; 2004 Jan; 308(1):300-6. PubMed ID: 14563787
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insights into the structural basis of substrate recognition by histidinol-phosphate aminotransferase from Corynebacterium glutamicum.
    Marienhagen J; Sandalova T; Sahm H; Eggeling L; Schneider G
    Acta Crystallogr D Biol Crystallogr; 2008 Jun; 64(Pt 6):675-85. PubMed ID: 18560156
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of human CYP1A2 oxidation of 5,6-dimethyl-xanthenone-4-acetic acid by acridines: a molecular modelling study.
    Paxton JW; Kestell P; Chiang D; Zhou S; Lewis DF
    Clin Exp Pharmacol Physiol; 2005 Aug; 32(8):633-9. PubMed ID: 16120190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The productive conformation of prostaglandin G2 at the peroxidase site of prostaglandin endoperoxide H synthase: docking, molecular dynamics, and site-directed mutagenesis studies.
    Chubb AJ; Fitzgerald DJ; Nolan KB; Moman E
    Biochemistry; 2006 Jan; 45(3):811-20. PubMed ID: 16411757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Arginine to lysine 108 substitution in recombinant CYP1A2 abolishes methoxyresorufin metabolism in lymphoblastoid cells.
    Hadjokas NE; Dai R; Friedman FK; Spence MJ; Cusack BJ; Vestal RE; Ma Y
    Br J Pharmacol; 2002 Jun; 136(3):347-52. PubMed ID: 12023936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the amino acid invariants in the active site of MurG as evaluated by site-directed mutagenesis.
    Crouvoisier M; Auger G; Blanot D; Mengin-Lecreulx D
    Biochimie; 2007 Dec; 89(12):1498-508. PubMed ID: 17692452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.
    Zhang Q; Yang J; Liang K; Feng L; Li S; Wan J; Xu X; Yang G; Liu D; Yang S
    J Chem Inf Model; 2008 Sep; 48(9):1802-12. PubMed ID: 18707092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.